Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Duprey

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Anesthesia and Analgesia|October 21, 2022
In ResponseMatthew S Duprey, John W Devlin
BMJ Open Respiratory Research|August 28, 2020
Is there an association between subjective sleep quality and daily delirium occurrence in critically ill adults? A post hoc analysis of a randomised controlled trialMatthew S Duprey, John W Devlin, Yoanna Skrobik
Intensive Care Medicine|January 31, 2024
How does haloperidol influence the long-term outcomes of delirium?John W Devlin, Matthew S Duprey, Timothy D Girard
American Journal of Respiratory and Critical Care Medicine|June 7, 2021
Reply to Murray and NewsomeMatthew S Duprey, Arjen J C Slooter, John W Devlin
Critical Care Medicine|February 22, 2022
The authors replyMatthew S Duprey, John W Devlin, Mark van den Boogaard
Critical Care Medicine|August 18, 2017
The Evidence Clash Between Statins and Delirium: Should They Stay, Should They Go, or Should They Be Started?Matthew S Duprey, Sara A Zekery-Saad, John W Devlin
American Journal of Respiratory and Critical Care Medicine|March 3, 2018
Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled TrialYoanna Skrobik, Matthew S Duprey, Nicholas S Hill, et al.
Intensive Care Medicine|September 18, 2016
The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trialMatthew S Duprey, Nada Al-Qadheeb, Russel Roberts, et al.
Critical Care Research and Practice|March 31, 2022
Naloxegol to Prevent Constipation in ICU Adults Receiving Opioids: A Randomized Double-Blind Placebo-Controlled Pilot TrialMatthew S Duprey, Harmony Allison, Erik Garpestad, et al.
Journal of Addiction Medicine|January 12, 2019
Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use DisorderJessica L Moreno, Sarah E Wakeman, Matthew S Duprey, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Anesthesia and Analgesia|October 21, 2022
In ResponseMatthew S Duprey, John W Devlin
BMJ Open Respiratory Research|August 28, 2020
Is there an association between subjective sleep quality and daily delirium occurrence in critically ill adults? A post hoc analysis of a randomised controlled trialMatthew S Duprey, John W Devlin, Yoanna Skrobik
Intensive Care Medicine|January 31, 2024
How does haloperidol influence the long-term outcomes of delirium?John W Devlin, Matthew S Duprey, Timothy D Girard
American Journal of Respiratory and Critical Care Medicine|June 7, 2021
Reply to Murray and NewsomeMatthew S Duprey, Arjen J C Slooter, John W Devlin
Critical Care Medicine|February 22, 2022
The authors replyMatthew S Duprey, John W Devlin, Mark van den Boogaard
Critical Care Medicine|August 18, 2017
The Evidence Clash Between Statins and Delirium: Should They Stay, Should They Go, or Should They Be Started?Matthew S Duprey, Sara A Zekery-Saad, John W Devlin
American Journal of Respiratory and Critical Care Medicine|March 3, 2018
Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled TrialYoanna Skrobik, Matthew S Duprey, Nicholas S Hill, et al.
Intensive Care Medicine|September 18, 2016
The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trialMatthew S Duprey, Nada Al-Qadheeb, Russel Roberts, et al.
Critical Care Research and Practice|March 31, 2022
Naloxegol to Prevent Constipation in ICU Adults Receiving Opioids: A Randomized Double-Blind Placebo-Controlled Pilot TrialMatthew S Duprey, Harmony Allison, Erik Garpestad, et al.
Journal of Addiction Medicine|January 12, 2019
Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use DisorderJessica L Moreno, Sarah E Wakeman, Matthew S Duprey, et al.
Pageof 4